Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?
Hausdorff WP, Hoet B, Schuerman L. Hausdorff WP, et al. Among authors: schuerman l. BMC Pediatr. 2010 Feb 2;10:4. doi: 10.1186/1471-2431-10-4. BMC Pediatr. 2010. PMID: 20122261 Free PMC article. Review.
Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model.
Cheuvart B, Burgess M, Zepp F, Mertsola J, Wolter J, Schuerman L. Cheuvart B, et al. Among authors: schuerman l. Vaccine. 2004 Dec 2;23(3):336-42. doi: 10.1016/j.vaccine.2004.06.012. Vaccine. 2004. PMID: 15530678
Diphtheria-tetanus-pertussis (DTP) combination vaccines and evaluation of pertussis immune responses.
Godfroid F, Denoël P, de Grave D, Schuerman L, Poolman J. Godfroid F, et al. Among authors: schuerman l. Int J Med Microbiol. 2004 Oct;294(5):269-76. doi: 10.1016/j.ijmm.2004.07.007. Int J Med Microbiol. 2004. PMID: 15532986 Review.
Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review.
Jacquet JM, Bégué P, Grimprel E, Reinert P, Sandbu S, Silfverdal SA, Faldella G, Nolan T, Lambert S, Richmond P, Marshall H, Roberton D, Schuerman L. Jacquet JM, et al. Among authors: schuerman l. Vaccine. 2006 Mar 20;24(13):2440-8. doi: 10.1016/j.vaccine.2005.12.009. Epub 2005 Dec 20. Vaccine. 2006. PMID: 16406224 Clinical Trial.
Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J. Henckaerts I, et al. Among authors: schuerman l. Vaccine. 2007 Mar 22;25(13):2518-27. doi: 10.1016/j.vaccine.2006.09.029. Epub 2006 Sep 20. Vaccine. 2007. PMID: 17034907
ELISA IgG concentrations and opsonophagocytic activity following pneumococcal protein D conjugate vaccination and relationship to efficacy against acute otitis media.
Schuerman L, Prymula R, Henckaerts I, Poolman J. Schuerman L, et al. Vaccine. 2007 Mar 1;25(11):1962-8. doi: 10.1016/j.vaccine.2006.12.008. Epub 2006 Dec 26. Vaccine. 2007. PMID: 17258357 Clinical Trial.
Kinetics of the immune response following pneumococcal PD conjugate vaccination.
Schuerman L, Prymula R, Chrobok V, Dieussaert I, Poolman J. Schuerman L, et al. Vaccine. 2007 Mar 1;25(11):1953-61. doi: 10.1016/j.vaccine.2006.12.007. Epub 2006 Dec 26. Vaccine. 2007. PMID: 17258358 Clinical Trial.
Immunogenicity and safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine.
Pichichero ME, Bernstein H, Blatter MM, Schuerman L, Cheuvart B, Holmes SJ; 085 Study Investigators. Pichichero ME, et al. Among authors: schuerman l. J Pediatr. 2007 Jul;151(1):43-9, 49.e1-2. doi: 10.1016/j.jpeds.2007.02.013. J Pediatr. 2007. PMID: 17586189 Clinical Trial.
Safety of the 11-valent pneumococcal vaccine conjugated to non-typeable Haemophilus influenzae-derived protein D in the first 2 years of life and immunogenicity of the co-administered hexavalent diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio virus, Haemophilus influenzae type b and control hepatitis A vaccines.
Prymula R, Chlibek R, Splino M, Kaliskova E, Kohl I, Lommel P, Schuerman L. Prymula R, et al. Among authors: schuerman l. Vaccine. 2008 Aug 18;26(35):4563-70. doi: 10.1016/j.vaccine.2008.05.080. Epub 2008 Jun 17. Vaccine. 2008. PMID: 18602724 Clinical Trial.
Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, Borys D, Cleerbout J, Lommel P, Schuerman L. Chevallier B, et al. Among authors: schuerman l. Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S109-18. doi: 10.1097/INF.0b013e318199f62d. Pediatr Infect Dis J. 2009. PMID: 19325447 Review.
103 results
Jump to page
Feedback